Aibotics, Inc. (AIBT)
0.0005
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Aibotics Enterprise Value : 1.418M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 1.418M |
| August 24, 2026 | 1.346M |
| August 21, 2026 | 1.418M |
| August 20, 2026 | 1.346M |
| August 19, 2026 | 1.346M |
| August 18, 2026 | 1.346M |
| August 17, 2026 | 1.274M |
| August 14, 2026 | 1.346M |
| August 13, 2026 | 1.346M |
| August 12, 2026 | 1.317M |
| August 11, 2026 | 1.346M |
| August 10, 2026 | 1.371M |
| August 07, 2026 | 1.379M |
| August 06, 2026 | 1.371M |
| August 05, 2026 | 1.418M |
| August 04, 2026 | 1.491M |
| August 03, 2026 | 1.491M |
| July 31, 2026 | 1.346M |
| July 30, 2026 | 1.346M |
| July 29, 2026 | 1.346M |
| July 28, 2026 | 1.31M |
| July 27, 2026 | 1.274M |
| July 24, 2026 | 1.346M |
| July 23, 2026 | 1.418M |
| July 22, 2026 | 1.418M |
| Date | Value |
|---|---|
| July 21, 2026 | 1.393M |
| July 20, 2026 | 1.418M |
| July 17, 2026 | 1.382M |
| July 16, 2026 | 1.393M |
| July 15, 2026 | 1.418M |
| July 14, 2026 | 1.418M |
| July 13, 2026 | 1.379M |
| July 10, 2026 | 1.418M |
| July 09, 2026 | 1.491M |
| July 08, 2026 | 1.491M |
| July 07, 2026 | 1.563M |
| July 06, 2026 | 1.563M |
| July 02, 2026 | 1.563M |
| July 01, 2026 | 1.476M |
| June 30, 2026 | 1.491M |
| June 29, 2026 | 1.447M |
| June 26, 2026 | 1.447M |
| June 25, 2026 | 1.501M |
| June 24, 2026 | 1.501M |
| June 23, 2026 | 1.501M |
| June 22, 2026 | 1.501M |
| June 18, 2026 | 1.501M |
| June 17, 2026 | 1.522M |
| June 16, 2026 | 1.501M |
| June 15, 2026 | 1.530M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CS Diagnostics Corp. | 2.620M |
| GeneDx Holdings Corp. | 2.640B |
| Ayujoy Herbals Ltd. | -- |
| Arrowhead Pharmaceuticals, Inc. | 12.32B |
| Oncolytics Biotech, Inc. | 103.70M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.537M |
| Total Expenses (Quarterly) | 0.537M |
| EPS Diluted (Quarterly) | -0.0008 |
| Earnings Yield | -1.10K% |
| Normalized Earnings Yield | -1040.00 |